Sanofi US Services INC (Formerly Known as Genzyme Corporation)

A bio company focused on developing and applying advanced technologies in the life science

Based in DC

🤖

AI Overview

With $2.0M in lobbying spend across 33 quarterly filings, Sanofi US Services INC (Formerly Known as Genzyme Corporation) is a significant lobbying presence. They deploy 12 individual lobbyists Their lobbying covers 5 issue areas. Active from 2018 to 2025.

$2.0M

Total Spend

Years Active

Firms Hired

Lobbyists Deployed

Issues Lobbied

Spending Trend

View as table

Year	Lobbying Spend
2018	$250K
2019	$240K
2020	$240K
2021	$240K
2022	$300K
2023	$240K
2024	$240K
2025	$240K

Issues Lobbied

Budget/Appropriations Taxation Copyright/Patent Health Issues Medicare/Medicaid

Lobbying Firms

Tarplin, Downs & Young, LLC

Lobbyists

Raissa Downs Jennifer Young Michelle Easton Elizabeth Murray Charlotte Ivancic Pamela Smith Emily Murry Kimberly Brandt Margaret Joseph Peter Fise Laura Friedel Parick Carroll

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Budget/Appropriations, Taxation, Copyright/Patent, Health Issues, Medicare/Medicaid

•budget resolution, reconciliation, deficit reduction, debt ceiling, apropriations
•H.R. 1625 - Consolidated Appropriations Act of 2018
•H.R. 1892 - Bipartisan Budget Act of 2018

•orphan drug tax credit

•Patent reform

•PL 114-255 - 21st Century Cures, implementation
•H.R. 878/S. 204 - Right to Try Act
•H.R. 1231/S. 456 - RACE for Children Act
•H.R. 2430 - FDA Reauthorization Act of 2017
•H.R. 849/S. 260 - Protecting Sen

•***, no specific bill(s), Medicare Reimbursement, Medicaid Rebate, Medicaid Coverage and Reimbursement, quality indicators, coding, oncology, CMMI, home infusion, Least Costly alternative, Part B, ASP